[Federal Register Volume 64, Number 5 (Friday, January 8, 1999)]
[Notices]
[Page 1208]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-381]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Open Meeting for Representatives of Health Professional 
Organizations

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing a public 
meeting with representatives of health professional organizations. The 
meeting will be chaired by Sharon Smith Holston, Deputy Commissioner 
for External Affairs. The agenda will include a presentation by Dr. 
Jane E. Henney, Commissioner of Food and Drugs, sharing her priorities 
for FDA and the relationship between the agency and the health 
professional community. Other topics on the agenda are the sale of 
prescription drugs on the internet and direct-to-consumer advertising 
of prescription drugs.

DATES: The meeting will be held on Monday, February 8, 1999, from 1:30 
p.m. to 3:30 p.m.

ADDRESSES: The meeting will be held at the Hyatt Regency Hotel, One 
Metro Center, Bethesda, MD.

FOR FURTHER INFORMATION CONTACT: Peter H. Rheinstein, Office of Health 
Affairs (HFY-40), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-6630.

    Those persons interested in attending this meeting should call 
Betty Palsgrove at 301-827-6618 to register. Registration also may be 
transmitted by fax to 1-800-344-3332 or 301-443-2446. Please include 
the name and title of the person attending, the name of the 
organization, address, and telephone number. There is no registration 
fee for this meeting, however, early registration is suggested because 
space is limited. Persons will be registered in the order in which 
calls are received.

SUPPLEMENTARY INFORMATION:  The purpose of the meeting is to provide an 
opportunity for representatives of health professional organizations 
and other interested persons to be briefed by senior FDA staff. It will 
also provide an opportunity for informal discussion on these topics of 
particular interest to health professional organizations.

    Dated: January 4, 1999.
William K. Hubbard,
Associate Commissioner for Policy Coordination.
[FR Doc. 99-381 Filed 1-7-99; 8:45 am]
BILLING CODE 4160-01-F